Jennifer Kay

9PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)Cancer cell biologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

|Nov 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

Lee J Pribyl, Jennifer E Kay, Joshua J Corrigan

|Jun 04, 2025
Sex and Alkyladenine DNA Glycosylase Expression are Key Susceptibility Factors for NDMA-induced Mutations, Toxicity, and Cancer.

Jennifer E Kay, Joshua J Corrigan, Lindsay B Volk

|Jan 10, 2024
Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available <i>in Vivo</i>, <i>in Vitro</i>, and <i>in Silico</i> Data.

Jennifer E Kay, Julia Green Brody, Megan Schwarzman

|Oct 14, 2022
Novel In Vivo CometChip Reveals NDMA-Induced DNA Damage and Repair in Multiple Mouse Tissues.

Norah A Owiti, Joshua J Corrigan, Lee J Pribyl

|Aug 19, 2022
Chemical Effects on Breast Development, Function, and Cancer Risk: Existing Knowledge and New Opportunities.

Jennifer E Kay, Bethsaida Cardona, Ruthann A Rudel

Pageof 2

Frequent Collaborators

3 joint publications

Bevin P Engelward

3 joint publications

John M Essigmann

3 joint publications

Lee J Pribyl

3 joint publications

Lindsay B Volk